ML-SA1 is primarily used in research settings to study the role of lysosomal function and autophagy in cellular processes. It is known to activate the TRPML1 (transient receptor potential mucolipin 1) channel, which plays a crucial role in lysosomal calcium signaling. Researchers utilize ML-SA1 to investigate its effects on cellular clearance mechanisms, particularly in neurodegenerative diseases where impaired autophagy and lysosomal dysfunction are often observed. Additionally, ML-SA1 is employed in studies exploring its potential therapeutic applications for conditions like Parkinson's disease, Alzheimer's disease, and other lysosomal storage disorders. Its ability to enhance lysosomal activity makes it a valuable tool for understanding and potentially treating diseases linked to lysosomal impairment.